New Web-Based Tracking and Sample Management System Introduced

It is fast, enabling sample data to be retrieved in seconds to support faster data analysis, 24/7 from anywhere in the world via a global database.

The system can find the exact storage location of sample assets by room, storage unit, and position in storage, and storing up to 999 data points associated with each sample. It allows access to a 21 CFR Part 11 compliant, uneditable database with a secure login to protect valuable scientific sample data for future utilization.

BioStorage Technologies (Indiana, IN, USA), a global leader in scientific asset management, cold chain logistics, and biomaterial storage for the bioscience industry, introduced the newest version of ISISS. This latest release includes enhanced search features, customized reporting capabilities, and intuitive sample tracking.

Designed specifically to meet the growing requirements of the global biobanking community, ISISS is maintained in compliance with both domestic and international standards, including the US Food and Drug Administration (FDA; Silver Spring, MD, USA) Title 21 CFR Part 11. The fast and easy-to-use system allows users to monitor sample status and activity, view audit trails and documentation, schedule shipments, and retrieve sample data on biological materials stored in BioStorage Technologies' global database.

Lori Ball, chief operating officer BioStorage Technologies said, "The globalization of clinical research, combined with the growth of biotech drug development, necessitates a cross-functional system that provides the customization and scalability required to efficiently manage growing biological sample inventories and their associated data.”

BioStorage Technologies, Inc. is the global leader in centralized sample management and onsite biorepository solutions for the bioscience industry. The company specializes in the management of biological samples including planning, collection, transportation, storage, and retrieval.

Related Links:
BioStorage Technologies
US Food and Drug Administration